市場調査レポート

商品コード

1085203

ウイルスベクターおよびプラスミドDNA検査サービスの世界市場：検査サービス別、エンドユーザー別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

Viral Vector and Plasmid DNA Testing Services Market, by Testing Services, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: 2022年05月20日 | 発行: Coherent Market Insights

| ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,500 700,920円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,090,320円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,557,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ウイルスベクターやプラスミドDNAを用いた様々な治療法の臨床検査が、予測期間中の市場の成長を促進すると期待されています。さらに、産業界におけるウイルスベクターやプラスミドDNAの利用に対して当局が課す規制も、市場の成長を促進すると予想されます。

当レポートでは、世界のウイルスベクターおよびプラスミドDNA検査サービス市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

ヒートマップ分析
市場シェア分析
- Charles River Laboratories, Inc.
- 製品ポートフォリオ
- WuXi AppTec Co., Ltd.
- 製品ポートフォリオ
- Cobra Biologics and Pharmaceutical Services
- 製品ポートフォリオ
- Merck KGaA
- 製品ポートフォリオ
- Lonza
- 製品ポートフォリオ
- Eurofins Scientific
- 製品ポートフォリオ
- FinVector Vision Therapies
- 製品ポートフォリオ
- Advanced Bioscience Laboratories, Inc.
- 製品ポートフォリオ
- Takara Bio Inc.
- 製品ポートフォリオ
- ViruSure GmbH
- 製品ポートフォリオ
- Genezen Laboratories
- 製品ポートフォリオ
アナリストの見解

第8章セクション

Product Code: CMI3637

Viral vectors are the best approach used in the gene therapies and therefore, testing services are the key factors for the timely development of viral vector-based therapies. Viral vector characterization plays an important role for orthogonal analytical approaches. The characterization is significant through the regulatory perspective, which include product safety, identity, purity, and potency. Nowadays, viral vector are the leading vehicle for the multiple virus-based drugs, which are approved in the global market and are developed for various treatments such as cancer and neurology, hematology, ophthalmology, and metabolic or muscular disorders. Viral-based products has the promising future in the pharmaceutical sector for many innovations.

The ongoing clinical trials on the viral vectors and plasmid DNA for various treatment is expected to fuel growth of the market in the forecast period. For instance, according to data published in the Journal of Gene Medicine, March 2021, till November 2017, around 2,600 gene therapy clinical trials were ongoing that are approved in 36 countries which include the U.S., the U.K., Australia, Canada, China, France, Germany, Japan, Switzerland, the Netherlands, and others. Moreover, diseases targeted by gene therapies include cardiovascular diseases, cancer, inflammatory and infectious diseases, Hemophilia A and B, severe combined immunodeficiency (SCID), ocular diseases, neurological diseases, and others.

Furthermore, favorable regulations imposed by the regulatory authorities for the specific utilization of viral vectors or plasmid DNA in the industries are expected to fuel growth of the market. For instance, in March 2021, the European Medicines Agency (EMA) drafted a guideline on the quality, non-clinical, and clinical aspects of gene therapy medicinal products, wherein the agency stated that characterization studies should be conducted throughout the development process right from starting materials, intermediates, drug substance and drug product in the gene therapy medicinal products (GTMP). The agency also stated that the characterization of the vector should include all components, but in particular, those present in the final product to be administered.

Market Dynamics

The viral vector and plasmid DNA testing services market is expected to witness significant growth over the forecast period, owing to rising number of business expansion by opening a new center or process development service (PDS). For instance, in February 2019, LakePharma, Inc., a contract research, development, and manufacturing organization (CRDMO), announced the availability of its vector center commercially located at Worcester, U.S. for offering broad range of services such as viral vector production, CAR-T engineering, analytical development of vectors, and others. The company also made lentivirus, adeno-associated virus (AAV), and baculovirus production systems available at the center.

Moreover, acquisitions by the major players are expected to drive growth of viral vector and plasmid DNA testing services market over the forecast period. For instance, in November 2021, ABL Europe SAS, a subsidiary of ABL, Inc., acquired a former Accinov GMP manufacturing site located in Lyon, France for expansion of viral vector GMP contract manufacturing capacity in the gene therapy space. The site has 3 GMP suites, laboratory and office, which provides process development, and analytical support for gene therapy.

Key features of the study:

This report provides in-depth analysis of the viral vector and plasmid DNA testing services market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global viral vector and plasmid DNA testing services market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as part of this study include Charles River Laboratories, Inc., WuXi AppTec Co., Ltd., Cobra Biologics and Pharmaceutical Services, Merck KGaA, Lonza, Eurofins Scientific, FinVector Vision Therapies, Advanced Bioscience Laboratories, Inc., Takara Bio Inc., ViruSure GmbH, and Genezen Laboratories amongst others

Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics

The global viral vector and plasmid DNA testing services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the viral vector and plasmid DNA testing services market

Detailed Segmentation:

Global viral vector and plasmid DNA testing services market, by testing services:

Safety

Genetic Characterization

Purity

Identity

Potency

Global viral vector and plasmid DNA testing services market, By end user:

Research Organizations

Pharmaceutical and Biotechnological Companies

Global viral vector and plasmid DNA testing services market, By Region:

North America

By Testing Services:

Safety

Genetic Characterization

Purity

Identity

Potency

By End User:

Research Organizations

Pharmaceutical and Biotechnological Companies

By Country:

U.S.

Canada

Latin America

By Testing Services:

Safety

Genetic Characterization

Purity

Identity

Potency

By End User:

Research Organizations

Pharmaceutical and Biotechnological Companies

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Testing Services:

Safety

Genetic Characterization

Purity

Identity

Potency

By End User:

Research Organizations

Pharmaceutical and Biotechnological Companies

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Testing Services:

Safety

Genetic Characterization

Purity

Identity

Potency

By End User:

Research Organizations

Pharmaceutical and Biotechnological Companies

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Pakistan

Rest of Asia Pacific

Middle East

By Testing Services:

Safety

Genetic Characterization

Purity

Identity

Potency

By End User:

Research Organizations

Pharmaceutical and Biotechnological Companies

By Country:

GCC

Israel

Rest of Middle East

Africa

By Testing Services:

Safety

Genetic Characterization

Purity

Identity

Potency

By End User:

Research Organizations

Pharmaceutical and Biotechnological Companies

By Country/Region:

North Africa

Central Africa

South Africa

Company Profiles

Charles River Laboratories, Inc.*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Market Strategies

WuXi AppTec Co., Ltd.

Cobra Biologics and Pharmaceutical Services

Merck KGaA

Lonza

Eurofins Scientific

FinVector Vision Therapies

Advanced Bioscience Laboratories, Inc.

Takara Bio Inc.

ViruSure GmbH

Genezen Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Testing Services
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
Regulatory Guidelines
Regulatory Scenario
Merger & Acquisitions
Product Launch
Epidemiology
Pipeline Analysis
New Product Launches
List of Approved Products
Pest Analysis

4. Global Viral Vector and Plasmid DNA Testing Services Market, By Testing Services, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Safety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Genetic Characterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Purity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Identity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Potency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Viral Vector and Plasmid DNA Testing Services Market, By End User, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Pharmaceutical and Biotechnological Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Viral Vector and Plasmid DNA Testing Services Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Testing Services, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Testing Services, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Testing Services, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Testing Services, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Pakistan
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Testing Services, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Testing Services, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Charles River Laboratories, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- WuXi AppTec Co., Ltd.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cobra Biologics and Pharmaceutical Services
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- FinVector Vision Therapies
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Advanced Bioscience Laboratories, Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ViruSure GmbH
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genezen Laboratories
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

8. Section

References
Research Methodology
About Us and Sales Contact

ウイルスベクターおよびプラスミドDNA検査サービスの世界市場：検査サービス別、エンドユーザー別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

Viral Vector and Plasmid DNA Testing Services Market, by Testing Services, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学、規制、および動向分析

第4章世界のウイルスベクターおよびプラスミドDNA検査サービス市場：テストサービス別（100万米ドル）（2017年～2028年）

第5章世界のウイルスベクターおよびプラスミドDNA検査サービス市場：エンドユーザー別（100万米ドル）（2017年～2028年）

第6章世界のウイルスベクターおよびプラスミドDNA検査サービス市場：地域別（100万米ドル）（2017年～2028年）

第7章競合情勢

第8章セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Viral Vector and Plasmid DNA Testing Services Market, By Testing Services, 2017 - 2028, (US$ Mn)

5. Global Viral Vector and Plasmid DNA Testing Services Market, By End User, 2017 - 2028, (US$ Mn)

6. Global Viral Vector and Plasmid DNA Testing Services Market, By Region, 2017 - 2028, (US$ Mn)

7. Competitive Landscape

8. Section

ウイルスベクターおよびプラスミドDNA検査サービスの世界市場：検査サービス別、エンドユーザー別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

Viral Vector and Plasmid DNA Testing Services Market, by Testing Services, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目次

第1章 調査目的・前提条件

第2章 市場の展望

第3章 市場力学、規制、および動向分析

第4章 世界のウイルスベクターおよびプラスミドDNA検査サービス市場：テストサービス別（100万米ドル）（2017年～2028年）

第5章 世界のウイルスベクターおよびプラスミドDNA検査サービス市場：エンドユーザー別（100万米ドル）（2017年～2028年）

第6章 世界のウイルスベクターおよびプラスミドDNA検査サービス市場：地域別（100万米ドル）（2017年～2028年）

第7章 競合情勢

第8章 セクション

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Viral Vector and Plasmid DNA Testing Services Market, By Testing Services, 2017 - 2028, (US$ Mn)

5. Global Viral Vector and Plasmid DNA Testing Services Market, By End User, 2017 - 2028, (US$ Mn)

6. Global Viral Vector and Plasmid DNA Testing Services Market, By Region, 2017 - 2028, (US$ Mn)

7. Competitive Landscape

8. Section

第1章調査目的・前提条件

第2章市場の展望

第3章市場力学、規制、および動向分析

第4章世界のウイルスベクターおよびプラスミドDNA検査サービス市場：テストサービス別（100万米ドル）（2017年～2028年）

第5章世界のウイルスベクターおよびプラスミドDNA検査サービス市場：エンドユーザー別（100万米ドル）（2017年～2028年）

第6章世界のウイルスベクターおよびプラスミドDNA検査サービス市場：地域別（100万米ドル）（2017年～2028年）

第7章競合情勢

第8章セクション